Trades on 1 secondary market

Stipple Bio

Stipple Bio is a preclinical precision-oncology biotechnology company based in Cambridge, Massachusetts, founded in 2022 by cancer-biology researchers Aaron Ring (Fred Hutch) and Aashish Manglik (UCSF). Its Pointillist Platform performs cellular profiling and tumor-specific epitope discovery to desi

minimal 7.7 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Oncology Precision Medicine Drug Discovery

Stipple Bio is an API provider whose private shares are listed on 1 secondary market: Forge Global.

Where It Trades

F Forge Global View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.